Summary

India Prosthetic Heart Valve Market
The India prosthetic heart valve market was valued at $159.9 million in 2023 and is projected to reach $519.7 million by 2033, growing at a CAGR of 12.5% from 2024 to 2033.

A prosthetic heart valve is an artificial instrument designed to substitute the impaired native valves of the human heart. Its efficient opening and closing at every heartbeat promote effective blood circulation throughout the body. Prosthetic valves are majorly of two types: bioprosthetic and mechanical. Bioprosthetic valves are developed using biological tissues derived from animals or humans and mechanical valves are fabricated from durable materials such as titanium or carbon. The longevity of these devices typically ranges from 20 to 30 years, minimizing the risk of blood clot formation on their surfaces.
The exponentially aging population in India is a key driver of the market as elderly individuals remain highly susceptible to cardiovascular diseases. In addition, upsurge in sedentary lifestyles and unhealthy dietary habits has increased the prevalence of heart diseases in middle-aged individuals, thereby propelling the development of the market. Furthermore, the implementation of several initiatives by the government to improve healthcare infrastructure and promote the affordability of treatments & medications is projected to fuel the demand for prosthetic heart valves in coming years. A notable trend gaining prominence in the India prosthetic heart valve market is the use of 3D printing technology for the development of the valves. They are created using specialized biopolymers with high biocompatibility and customization ability, eliminating the risks associated with existing synthetic valves such as thrombotic and thromboembolic complications.

However, shortage of efficient doctors and manpower hinders the effective and timely delivery of healthcare in India. This exhibits an impact on the requirement for prosthetic heart valves and restrains the growth of the market. Moreover, lack of efficient resources and infrastructure in the remote locations of India limits the utility of valves, hampering the market development significantly. On the contrary, rise in medical tourism in the country due to the availability of advanced medical technologies in urban settings is anticipated to present lucrative opportunities for the India prosthetic heart valve market. According to EY, a British accounting firm, the number of medical tourists visiting India crossed the mark of 0.5 million in 2023. This number is further projected to increase in the future and open new avenues for the market.

Segment Review
The India prosthetic heart valve market is segmented by product. On the basis of product, the market is divided into tissue heart valve, mechanical heart valve, and transcatheter heart valve.
Key Findings
On the basis of product, the transcatheter heart valve segment held a high share of the market in 2023.
Competition Analysis
The leading players operating in the global India prosthetic heart valve market include Edwards Lifesciences Corporation, TTK, SMT, Relisys Medical Devices Limited, Medtronic, Heart Care India Co., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., P+F Products + Features GmbH, Abbott Laboratories, and NeoCor CJSC. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:
● Quarterly Update and* (only available with a corporate license, on listed price)
● 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
● Free Upcoming Version on the Purchase of Five and Enterprise User License.
● 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
● 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
● Free data Pack on the Five and Enterprise User License. (Excel version of the report)
● Free Updated report if the report is 6-12 months old or older.
● 24-hour priority response*
● Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
● Regulatory Guidelines
● Additional company profiles with specific to client's interest
● Additional country or region analysis- market size and forecast
● Expanded list for Company Profiles
● Historic market data
● Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Product
● Tissue Heart Valve
○ Stented Tissue Heart Valve
○ Stentless Tissue Heart Valve
● Mechanical Heart Valve
● Transcatheter Heart Valve
● Key Market Players
○ Edwards Lifesciences Corporation
○ TTK
○ SMT
○ Relisys Medical Devices Limited.
○ Medtronic
○ Heart Care India Co
○ Boston Scientific Corporation
○ Meril Life Sciences Pvt. Ltd.
○ P+F Products + Features GmbH
○ Abbott Laboratories
○ NeoCor CJSC

ページTOPに戻る

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT
4.1. Market Overview
4.1.1 Market Size and Forecast, By Product
4.2. Tissue Heart Valve
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Stented Tissue Heart Valve
4.2.3. Stentless Tissue Heart Valve
4.3. Mechanical Heart Valve
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.4. Transcatheter Heart Valve
4.4.1. Key Market Trends, Growth Factors and Opportunities
CHAPTER 5: COMPETITIVE LANDSCAPE
5.1. Introduction
5.2. Top Winning Strategies
5.3. Product Mapping Of Top 10 Player
5.4. Competitive Dashboard
5.5. Competitive Heatmap
5.6. Top Player Positioning,2023
CHAPTER 6: COMPANY PROFILES
6.1. Edwards Lifesciences Corporation
6.1.1. Company Overview
6.1.2. Key Executives
6.1.3. Company Snapshot
6.1.4. Operating Business Segments
6.1.5. Product Portfolio
6.1.6. Business Performance
6.1.7. Key Strategic Moves and Developments
6.2. TTK
6.2.1. Company Overview
6.2.2. Key Executives
6.2.3. Company Snapshot
6.2.4. Operating Business Segments
6.2.5. Product Portfolio
6.2.6. Business Performance
6.2.7. Key Strategic Moves and Developments
6.3. SMT
6.3.1. Company Overview
6.3.2. Key Executives
6.3.3. Company Snapshot
6.3.4. Operating Business Segments
6.3.5. Product Portfolio
6.3.6. Business Performance
6.3.7. Key Strategic Moves and Developments
6.4. Relisys Medical Devices Limited.
6.4.1. Company Overview
6.4.2. Key Executives
6.4.3. Company Snapshot
6.4.4. Operating Business Segments
6.4.5. Product Portfolio
6.4.6. Business Performance
6.4.7. Key Strategic Moves and Developments
6.5. Medtronic
6.5.1. Company Overview
6.5.2. Key Executives
6.5.3. Company Snapshot
6.5.4. Operating Business Segments
6.5.5. Product Portfolio
6.5.6. Business Performance
6.5.7. Key Strategic Moves and Developments
6.6. Heart Care India Co
6.6.1. Company Overview
6.6.2. Key Executives
6.6.3. Company Snapshot
6.6.4. Operating Business Segments
6.6.5. Product Portfolio
6.6.6. Business Performance
6.6.7. Key Strategic Moves and Developments
6.7. Boston Scientific Corporation
6.7.1. Company Overview
6.7.2. Key Executives
6.7.3. Company Snapshot
6.7.4. Operating Business Segments
6.7.5. Product Portfolio
6.7.6. Business Performance
6.7.7. Key Strategic Moves and Developments
6.8. Meril Life Sciences Pvt. Ltd.
6.8.1. Company Overview
6.8.2. Key Executives
6.8.3. Company Snapshot
6.8.4. Operating Business Segments
6.8.5. Product Portfolio
6.8.6. Business Performance
6.8.7. Key Strategic Moves and Developments
6.9. P+F Products + Features GmbH
6.9.1. Company Overview
6.9.2. Key Executives
6.9.3. Company Snapshot
6.9.4. Operating Business Segments
6.9.5. Product Portfolio
6.9.6. Business Performance
6.9.7. Key Strategic Moves and Developments
6.10. Abbott Laboratories
6.10.1. Company Overview
6.10.2. Key Executives
6.10.3. Company Snapshot
6.10.4. Operating Business Segments
6.10.5. Product Portfolio
6.10.6. Business Performance
6.10.7. Key Strategic Moves and Developments
6.11. NeoCor CJSC
6.11.1. Company Overview
6.11.2. Key Executives
6.11.3. Company Snapshot
6.11.4. Operating Business Segments
6.11.5. Product Portfolio
6.11.6. Business Performance
6.11.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. INDIA PROSTHETIC HEART VALVE MARKET, BY PRODUCT, 2024 - 2033 ($MILLION)
TABLE 2. EDWARDS LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 3. EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 4. EDWARDS LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 5. EDWARDS LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 6. EDWARDS LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 7. TTK: KEY EXECUTIVES
TABLE 8. TTK: COMPANY SNAPSHOT
TABLE 9. TTK: OPERATING SEGMENTS
TABLE 10. TTK: PRODUCT PORTFOLIO
TABLE 11. TTK: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 12. SMT: KEY EXECUTIVES
TABLE 13. SMT: COMPANY SNAPSHOT
TABLE 14. SMT: OPERATING SEGMENTS
TABLE 15. SMT: PRODUCT PORTFOLIO
TABLE 16. SMT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 17. RELISYS MEDICAL DEVICES LIMITED.: KEY EXECUTIVES
TABLE 18. RELISYS MEDICAL DEVICES LIMITED.: COMPANY SNAPSHOT
TABLE 19. RELISYS MEDICAL DEVICES LIMITED.: OPERATING SEGMENTS
TABLE 20. RELISYS MEDICAL DEVICES LIMITED.: PRODUCT PORTFOLIO
TABLE 21. RELISYS MEDICAL DEVICES LIMITED.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 22. MEDTRONIC: KEY EXECUTIVES
TABLE 23. MEDTRONIC: COMPANY SNAPSHOT
TABLE 24. MEDTRONIC: OPERATING SEGMENTS
TABLE 25. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 26. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 27. HEART CARE INDIA CO: KEY EXECUTIVES
TABLE 28. HEART CARE INDIA CO: COMPANY SNAPSHOT
TABLE 29. HEART CARE INDIA CO: OPERATING SEGMENTS
TABLE 30. HEART CARE INDIA CO: PRODUCT PORTFOLIO
TABLE 31. HEART CARE INDIA CO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 32. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 33. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 34. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 35. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 36. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 37. MERIL LIFE SCIENCES PVT. LTD. : KEY EXECUTIVES
TABLE 38. MERIL LIFE SCIENCES PVT. LTD. : COMPANY SNAPSHOT
TABLE 39. MERIL LIFE SCIENCES PVT. LTD. : OPERATING SEGMENTS
TABLE 40. MERIL LIFE SCIENCES PVT. LTD. : PRODUCT PORTFOLIO
TABLE 41. MERIL LIFE SCIENCES PVT. LTD. : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 42. P+F PRODUCTS + FEATURES GMBH: KEY EXECUTIVES
TABLE 43. P+F PRODUCTS + FEATURES GMBH: COMPANY SNAPSHOT
TABLE 44. P+F PRODUCTS + FEATURES GMBH: OPERATING SEGMENTS
TABLE 45. P+F PRODUCTS + FEATURES GMBH: PRODUCT PORTFOLIO
TABLE 46. P+F PRODUCTS + FEATURES GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 47. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 48. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 49. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 50. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 51. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 52. NEOCOR CJSC : KEY EXECUTIVES
TABLE 53. NEOCOR CJSC : COMPANY SNAPSHOT
TABLE 54. NEOCOR CJSC : OPERATING SEGMENTS
TABLE 55. NEOCOR CJSC : PRODUCT PORTFOLIO
TABLE 56. NEOCOR CJSC : KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 2. SEGMENTATION OF INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN INDIA PROSTHETIC HEART VALVE MARKET,2024 - 2033
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: INDIA PROSTHETIC HEART VALVE MARKET
FIGURE 10. INDIA PROSTHETIC HEART VALVE MARKET , BY PRODUCT,2024 - 2033 ($MILLION)
FIGURE 11. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 12. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 13. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 14. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 15. COMPETITIVE DASHBOARD
FIGURE 16. COMPETITIVE HEATMAP: INDIA PROSTHETIC HEART VALVE MARKET
FIGURE 17. TOP PLAYER POSITIONING,2023
FIGURE 18. EDWARDS LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 19. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 20. EDWARDS LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 21. TTK: NET SALES, 2021-2023 ($MILLION)
FIGURE 22. TTK: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 23. TTK: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 24. SMT: NET SALES, 2021-2023 ($MILLION)
FIGURE 25. SMT: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 26. SMT: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 27. RELISYS MEDICAL DEVICES LIMITED.: NET SALES, 2021-2023 ($MILLION)
FIGURE 28. RELISYS MEDICAL DEVICES LIMITED.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 29. RELISYS MEDICAL DEVICES LIMITED.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 30. MEDTRONIC: NET SALES, 2021-2023 ($MILLION)
FIGURE 31. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. MEDTRONIC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. HEART CARE INDIA CO: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. HEART CARE INDIA CO: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. HEART CARE INDIA CO: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. MERIL LIFE SCIENCES PVT. LTD. : NET SALES, 2021-2023 ($MILLION)
FIGURE 40. MERIL LIFE SCIENCES PVT. LTD. : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. MERIL LIFE SCIENCES PVT. LTD. : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. P+F PRODUCTS + FEATURES GMBH: NET SALES, 2021-2023 ($MILLION)
FIGURE 43. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. P+F PRODUCTS + FEATURES GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($MILLION)
FIGURE 46. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. NEOCOR CJSC : NET SALES, 2021-2023 ($MILLION)
FIGURE 49. NEOCOR CJSC : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. NEOCOR CJSC : REVENUE SHARE, BY REGION, 2023 (%)